Service de Transplantation Rénale et Soins Intensifs, Hôpital Necker et Université Paris Descartes, Paris, France.
Transpl Int. 2013 Aug;26(8):795-9. doi: 10.1111/tri.12130. Epub 2013 Jun 5.
The clinical and bacteriological consequences of routinely performing highly sensitive bacterial screening of kidney transplant preservation solution (PS) are not known. To evaluate the clinical and microbiological impacts of this strategy, we retrospectively analyzed 200 consecutive kidney allograft recipients from March 2009 to February 2011 for whom PS samples were routinely screened. PS were inoculated into aerobic and anaerobic blood culture bottles, as well as blood agar plates. A rectal swab for extended-spectrum β-lactamase-producing Enterobacteriaceae (EBSL-PE) faecal carriage was also routinely obtained from each patient at admission and every 7 days until hospital discharge. In addition, a standard culture of drain fluid was collected on the day after kidney transplantation. Complete samples and cultures of PS were performed in 165 cases (82.5%), and 62 (37.6%) had positive blood culture results. The most frequent microbial agent isolated was coagulase-negative staphylococci (51.8%). Of these 62 positive samples, only seven (11.3%) were confirmed to contain the same organism by the standard culture method. Drain fluid and PS culture positivity with the same microorganism occurred in only two patients. Of the 62 patients with positive PS cultures, 26 (41.9%) received pre-emptive antibiotic therapy initiated within 48 h post-transplant. During the hospitalization period, patients with a positive PS culture, regardless of whether they received pre-emptive antibiotic therapy, did not exhibit any invasive infections (urinary, blood, peritoneal or wound) related to the microorganisms isolated in the PS. Patients with positive PS cultures who were treated with antibiotic therapy acquired significantly more colonizing ESBL-PE than patients who did not receive antibiotics (53.8% vs. 16.6%; P = 0.01); these patients also developed more clinical infections related to the ESBL-PE (23.1% vs. 5.2%; P < 0.01). The use of antibiotics for patients with positive PS cultures was an independent risk factor for ESBL-PE acquisition in both univariate and multivariate analyses. In conclusion, the use of more sensitive culture methods increases the rate of bacterial contamination of PS and is associated with an increased prescription of antibiotics and increased ESBL-PE carriage and related infections. Therefore, the systematic use of PS blood bottle cultures in kidney transplantation may have no benefit and might increase the rate of ESBL-PE emergence.
常规进行肾移植保存液(PS)高度敏感细菌筛选的临床和细菌学后果尚不清楚。为了评估该策略的临床和微生物学影响,我们回顾性分析了 200 例连续接受肾移植的患者,这些患者的 PS 样本均进行了常规筛查。PS 接种到需氧和厌氧血培养瓶以及血琼脂平板中。每位患者入院时和住院期间每 7 天还常规从直肠采集产超广谱β-内酰胺酶肠杆菌科(EBSL-PE)粪便携带的拭子。此外,在肾移植后第一天还采集引流液的标准培养物。在 165 例(82.5%)中完成了 PS 的完整样本和培养,其中 62 例(37.6%)血培养阳性。最常分离到的微生物是凝固酶阴性葡萄球菌(51.8%)。在这 62 个阳性样本中,只有 7 个(11.3%)通过标准培养方法证实含有相同的病原体。仅在 2 例患者中出现了相同微生物的引流液和 PS 培养阳性。在 62 例 PS 培养阳性的患者中,26 例(41.9%)在移植后 48 小时内接受了预防性抗生素治疗。在住院期间,无论是否接受预防性抗生素治疗,PS 培养阳性的患者均未出现与 PS 中分离的微生物相关的任何侵袭性感染(尿路、血液、腹膜或伤口)。接受抗生素治疗的 PS 培养阳性患者比未接受抗生素治疗的患者定植 ESBL-PE 的比例显著更高(53.8%比 16.6%;P=0.01);这些患者也发生了更多与 ESBL-PE 相关的临床感染(23.1%比 5.2%;P<0.01)。PS 培养阳性患者使用抗生素是单变量和多变量分析中 ESBL-PE 定植的独立危险因素。总之,使用更敏感的培养方法会增加 PS 细菌污染的发生率,并与抗生素的使用增加以及 ESBL-PE 定植和相关感染的增加相关。因此,在肾移植中系统使用 PS 血瓶培养可能没有益处,反而可能增加 ESBL-PE 的出现率。